Characterisation of infections in patients with acute myeloid leukaemia receiving venetoclax and a hypomethylating agent.
On S, Rath CG, Lan M, Wu B, Lau KM, Cheung E, Alegria W, Young R, Tan M, Kim C, Phun J, Patel N, Mannis G, Logan AC, Kennedy V, Goodman A, Taplitz RA, Young PA, Wen R, Saunders IM.
On S, et al.
Br J Haematol. 2022 Apr;197(1):63-70. doi: 10.1111/bjh.18051. Epub 2022 Feb 16.
Br J Haematol. 2022.
PMID: 35174480